Group dance interventions improved physical performance and cognition in community-dwelling older adults with sarcopenia.

This mixed methods systematic review and meta-analysis examined the efficacy of group dance interventions for sarcopenia in community-dwelling older adults. The analysis included a total sample size of 1840 participants drawn from community settings. The study design aggregated data from multiple sources to assess the impact of nine distinct types of group dance interventions. No specific comparator group was reported in the input data, and the study phase was not specified. The primary outcome metric was not explicitly defined in the provided evidence, though secondary outcomes provided detailed quantitative results.

Regarding physical performance and balance, the meta-analysis demonstrated significant improvements in the Short Physical Performance Battery, with a mean difference (MD) of 1.32 and a 95% confidence interval (CI) of 0.56 to 2.08. Significant gains were also noted in the Sit and Reach Test, showing an MD of 1.91 (95% CI: 0.29, 2.91). Cognitive function assessments revealed significant improvements on the Montreal Cognitive Assessment, with an MD of 0.94 (95% CI: 0.01, 1.87), and on the Trail Making Test, which showed a standardized mean difference (SMD) of 0.12 (95% CI: 0.03, 0.21). Absolute numbers for these outcomes were not reported in the source data.

In contrast to the positive findings in balance and cognition, the analysis found no significant differences for several functional mobility and strength measures. Specifically, muscle strength, the 5 times Sit-To-Stand test, Time Up and Go, Single Leg Test, 30s Chair Stand, and gait speed all showed no significant difference between intervention groups. Effect sizes and confidence intervals for these negative findings were not reported in the input data. The lack of reported data for these specific metrics limits the ability to quantify the magnitude of the null effects.

Safety and tolerability findings were not reported in the available evidence. Neither general adverse events nor serious adverse events were documented. This omission represents a significant limitation for clinical decision-making, as clinicians cannot assess the risk-benefit profile of these interventions based on the current data. The absence of safety data is particularly relevant for older adults, who may be more susceptible to falls or other complications during physical activity.

When compared to prior landmark studies in sarcopenia management, this review suggests that group dance may offer specific benefits for balance and cognitive function without necessarily improving raw muscle strength or gait speed in the short term. However, without direct comparisons to other exercise modalities or specific control groups in the input data, definitive conclusions regarding superiority over standard care cannot be drawn. The review highlights that while dance improves functional performance metrics like the Short Physical Performance Battery, it does not appear to significantly alter traditional strength or gait speed outcomes in this specific population.

Key methodological limitations include the lack of reported comparators, the absence of specific dosing or protocol details for the nine dance types, and the missing safety data. The study phase was not reported, which prevents assessment of whether these findings reflect early-phase efficacy or long-term maintenance. Potential biases related to the heterogeneity of the nine dance intervention types and the community-based setting were not explicitly addressed in the provided text. These factors contribute to uncertainty regarding the generalizability of the results to clinical practice.

The clinical implications suggest that group dance interventions may be a viable option for improving balance and cognitive function in community-dwelling older adults with sarcopenia. However, clinicians should remain cautious given the lack of safety data and the failure to demonstrate improvements in key strength and gait metrics. Practice decisions should consider that while balance and cognition improve, the intervention may not address all aspects of sarcopenia management, such as maximal muscle strength or gait velocity. Further research with standardized protocols and safety reporting is needed to refine these recommendations.

Several questions remain unanswered based on this evidence. The specific mechanisms by which dance improves cognitive scores without altering gait speed require further investigation. The optimal frequency and duration of dance sessions for sarcopenia management were not detailed in the input. Additionally, the long-term sustainability of the observed improvements in the Short Physical Performance Battery and cognitive tests is unknown. Clinicians must await more robust data before integrating these findings into standard care protocols for sarcopenia.